Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 30424
Evènement :Oncolytic Virotherapy Summit

Dates :Mardi 03 Décembre 2019 - Jeudi 05 Décembre 2019

Lieu :The Westin Boston Waterfront
425 Summer Street
02210 Boston, Massachusetts, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

The Oncolytic Virotherapy Summit is back for its fifth year as the only conference to bring together industry leaders, clinicians and academic experts focused on finding an effective immuno-oncology.
Over 3 days packed with compelling case studies, diverse panels and varied networking opportunities, you'll glean insights from industry and academic leaders. The 2019 agenda will reflect the strides taken by the community over the past year as well as forming the future of oncolytic virus development.
URLs:
Time: 08:00 to 16:00
Prices:
Conference Only : USD 2399.0,
Conference + 1 Workshop: USD 2999.0,
Conference + 2 Workshops: USD 3399.0
Speakers: Lance Weed, Vice President Operations, uniQure, Anton Xavier, Founder, K9 Biotech, Michael Wood MBA, Founder and Chief Operating Officer, OncoMyx, Robert Coffin, CEO, Replimmune, Daniel Katzman, CEO, Unleash Immuno Oncolytics, Dr Erik Digman Wiklund, Chief Business Officer, Targovax ASA, Michael Moore, Vice President Investor Relations and Corporate Communications, Oncolytics Biotech, David Sherris, President and Chief Executive Officer, GenAdam Therapeutics Inc., Louis Cantolupo, Chief Operating Officer, Unleash Immuno Oncolytics, Christophe Quéva, Chief Scientific Officer, Oncorus, Sridhar Pennathur, Senior Director and Fellow Biopharmaceutical Development, AstraZeneca, Dr John Goldberg, Senior Vice President Clinical Development and Practicing Paediatric Oncologist, Oncorus, Brian Haines PhD, Senior Director Pharmacology and Toxicology, Oncorus, Lorena Lerner, Vice President Molecular Biology and Virology, Oncorus, Beatriz Mesa, Senior Director Oncolytic Virus Manufacturing, Sorrento Therapeutics, Steve Thorne, Chief Scientific Officer, Western Oncolytics, Shara Dellatore, Principal Scientist and Group Leader, Merck, Angelica Loskog, CEO, Lokon Pharma, Maritza McIntyre, Former Chief Gene Therapy Branch, FDA

Lieu

Plan et itinéraire
Adresse de la conférence :
The Westin Boston Waterfront
425 Summer Street
02210 Boston
Massachusetts, États-Unis
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

Oncolytic Virotherapy Summit Médecine
--
Tout public
-- -- --
English

Divers

Pour plus d'informations sur Oncolytic Virotherapy Summit, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement